These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 31071294)

  • 1. Bacteroides-Derived Sphingolipids Are Critical for Maintaining Intestinal Homeostasis and Symbiosis.
    Brown EM; Ke X; Hitchcock D; Jeanfavre S; Avila-Pacheco J; Nakata T; Arthur TD; Fornelos N; Heim C; Franzosa EA; Watson N; Huttenhower C; Haiser HJ; Dillow G; Graham DB; Finlay BB; Kostic AD; Porter JA; Vlamakis H; Clish CB; Xavier RJ
    Cell Host Microbe; 2019 May; 25(5):668-680.e7. PubMed ID: 31071294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomics Analysis of Outer Membrane Vesicles and Elucidation of the Inositol Phosphoceramide Biosynthetic Pathway in Bacteroides thetaiotaomicron.
    Sartorio MG; Valguarnera E; Hsu FF; Feldman MF
    Microbiol Spectr; 2022 Feb; 10(1):e0063421. PubMed ID: 35080445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids.
    Le HH; Lee MT; Besler KR; Johnson EL
    Cell Host Microbe; 2022 Jun; 30(6):798-808.e7. PubMed ID: 35623356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels.
    Johnson EL; Heaver SL; Waters JL; Kim BI; Bretin A; Goodman AL; Gewirtz AT; Worgall TS; Ley RE
    Nat Commun; 2020 May; 11(1):2471. PubMed ID: 32424203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4
    Li K; Hao Z; Du J; Gao Y; Yang S; Zhou Y
    Int Immunopharmacol; 2021 Jan; 90():107183. PubMed ID: 33229197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mucin-responsive hybrid two-component system controls Bacteroides thetaiotaomicron colonization and gut homeostasis.
    Lee JH; Kwon SJ; Han JY; Cho SH; Cho YJ; Park JH
    J Microbiol; 2022 Feb; 60(2):215-223. PubMed ID: 35102527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of inositol lipid metabolism in gut-associated Bacteroidetes.
    Heaver SL; Le HH; Tang P; Baslé A; Mirretta Barone C; Vu DL; Waters JL; Marles-Wright J; Johnson EL; Campopiano DJ; Ley RE
    Nat Microbiol; 2022 Jul; 7(7):986-1000. PubMed ID: 35725777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine.
    An D; Na C; Bielawski J; Hannun YA; Kasper DL
    Proc Natl Acad Sci U S A; 2011 Mar; 108 Suppl 1(Suppl 1):4666-71. PubMed ID: 20855611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of 3-ketosphinganine reductase activity encoded at the BT_0972 locus in Bacteroides thetaiotaomicron.
    Lee MT; Le HH; Besler KR; Johnson EL
    J Lipid Res; 2022 Jul; 63(7):100236. PubMed ID: 35667415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatially resolved lipidomics shows conditional transfer of lipids produced by Bacteroides thetaiotaomicron into the mouse gut.
    Mirretta Barone C; Heaver SL; Gruber L; Zundel F; Vu DL; Ley RE
    Cell Host Microbe; 2024 Jun; 32(6):1025-1036.e5. PubMed ID: 38795710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles produced by the human commensal gut bacterium Bacteroides thetaiotaomicron affect host immune pathways in a cell-type specific manner that are altered in inflammatory bowel disease.
    Gul L; Modos D; Fonseca S; Madgwick M; Thomas JP; Sudhakar P; Booth C; Stentz R; Carding SR; Korcsmaros T
    J Extracell Vesicles; 2022 Jan; 11(1):e12189. PubMed ID: 35064769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective gut bacterial bile salt hydrolase alters host metabolism.
    Yao L; Seaton SC; Ndousse-Fetter S; Adhikari AA; DiBenedetto N; Mina AI; Banks AS; Bry L; Devlin AS
    Elife; 2018 Jul; 7():. PubMed ID: 30014852
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Schaus SR; Vasconcelos Pereira G; Luis AS; Madlambayan E; Terrapon N; Ostrowski MP; Jin C; Henrissat B; Hansson GC; Martens EC
    mBio; 2024 Aug; 15(8):e0003924. PubMed ID: 38975756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Metabolic Pathway for Activation of Dietary Glucosinolates by a Human Gut Symbiont.
    Liou CS; Sirk SJ; Diaz CAC; Klein AP; Fischer CR; Higginbottom SK; Erez A; Donia MS; Sonnenburg JL; Sattely ES
    Cell; 2020 Feb; 180(4):717-728.e19. PubMed ID: 32084341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenosiderophore Utilization Promotes Bacteroides thetaiotaomicron Resilience during Colitis.
    Zhu W; Winter MG; Spiga L; Hughes ER; Chanin R; Mulgaonkar A; Pennington J; Maas M; Behrendt CL; Kim J; Sun X; Beiting DP; Hooper LV; Winter SE
    Cell Host Microbe; 2020 Mar; 27(3):376-388.e8. PubMed ID: 32075741
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Xiao X; Le HH; Lee M-T; Lamm D; Johnson EL; Brito IL
    mBio; 2024 Feb; 15(2):e0240923. PubMed ID: 38236049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Biosynthesis of Lipooligosaccharide from
    Jacobson AN; Choudhury BP; Fischbach MA
    mBio; 2018 Mar; 9(2):. PubMed ID: 29535205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipids in host-microbial interactions.
    Heaver SL; Johnson EL; Ley RE
    Curr Opin Microbiol; 2018 Jun; 43():92-99. PubMed ID: 29328957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces.
    Abdel Hadi L; Di Vito C; Riboni L
    Mediators Inflamm; 2016; 2016():3827684. PubMed ID: 26880864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microbial symbiosis factor prevents intestinal inflammatory disease.
    Mazmanian SK; Round JL; Kasper DL
    Nature; 2008 May; 453(7195):620-5. PubMed ID: 18509436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.